4//SEC Filing
Shah Pritesh 4
Accession 0001645113-22-000031
CIK 0001645113other
Filed
Mar 10, 7:00 PM ET
Accepted
Mar 11, 4:54 PM ET
Size
8.3 KB
Accession
0001645113-22-000031
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Shah Pritesh
Chief Commercial Officer
Transactions
- Sale
Ordinary Shares
2022-03-09$71.19/sh−3,669$261,196→ 83,187 total - Exercise/Conversion
Restricted Stock Units
2021-07-31−3,717→ 3,717 totalExercise: $0.00From: 2021-07-31→ Ordinary Shares (3,717 underlying) - Exercise/Conversion
Ordinary Shares
2021-07-31$154.01/sh+3,717$572,455→ 85,625 total
Footnotes (3)
- [F1]Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Shah.
- [F2]Amended total to correct prior mathematical error.
- [F3]Fully vested as of the date hereof.
Documents
Issuer
NovoCure Ltd
CIK 0001645113
Entity typeother
Related Parties
1- filerCIK 0001744884
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 7:00 PM ET
- Accepted
- Mar 11, 4:54 PM ET
- Size
- 8.3 KB